{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:14:51Z","timestamp":1761182091134,"version":"build-2065373602"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"DOI":"10.7759\/cureus.95175","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:51:57Z","timestamp":1761155517000},"source":"Crossref","is-referenced-by-count":0,"title":["Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Metastatic Pancreatic Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Jacqueline","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63385","article-title":"Gemcitabine-induced thrombotic microangiopathy in a patient with cholangiocarcinoma: an atypical case","volume":"16","author":"Anil V","year":"2024","unstructured":"Anil V, Alhujaily E, Grover D, et al.. Gemcitabine-induced thrombotic microangiopathy in a patient with cholangiocarcinoma: an atypical case. Cureus. 2024, 16:e63385. 10.7759\/cureus.63385","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12261","article-title":"Gemcitabine-induced thrombotic microangiopathy","volume":"43","author":"Richmond J","year":"2013","unstructured":"Richmond J, Gilbar P, Abro E. Gemcitabine-induced thrombotic microangiopathy. Intern Med J. 2013, 43:1240-2. 10.1111\/imj.12261","journal-title":"Intern Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-22-509","article-title":"Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report","volume":"13","author":"Van den Eeckhaut L","year":"2022","unstructured":"Van den Eeckhaut L, Hannon H, Schurgers M, et al.. Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report. J Gastrointest Oncol. 2022, 13:3314-20. 10.21037\/jgo-22-509","journal-title":"J Gastrointest Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13031","article-title":"A case of gemcitabine-induced thrombotic microangiopathy treated with ravulizumab in a patient with Stage IV pancreatic cancer","volume":"13","author":"MacDougall KN","year":"2021","unstructured":"MacDougall KN, Schwartz B, Harewood J, et al.. A case of gemcitabine-induced thrombotic microangiopathy treated with ravulizumab in a patient with Stage IV pancreatic cancer. Cureus. 2021, 13:e13031. 10.7759\/cureus.13031","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13808","article-title":"Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort","volume":"85","author":"Daviet F","year":"2019","unstructured":"Daviet F, Rouby F, Poullin P, et al.. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. Br J Clin Pharmacol. 2019, 85:403-12. 10.1111\/bcp.13808","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0036","article-title":"Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome","volume":"12","author":"Mauch TJ","year":"2023","unstructured":"Mauch TJ, Chladek MR, Cataland S, et al.. Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome. J Comp Eff Res. 2023, 12:e230036. 10.57264\/cer-2023-0036","journal-title":"J Comp Eff Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03638-3","article-title":"Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data","volume":"25","author":"Sch\u00f6nfelder K","year":"2024","unstructured":"Sch\u00f6nfelder K, K\u00fchne L, Schulte-Kemna L, et al.. Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data. BMC Nephrol. 2024, 25:202. 10.1186\/s12882-024-03638-3","journal-title":"BMC Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358772-gemcitabine-induced-thrombotic-microangiopathy-in-a-patient-with-metastatic-pancreatic-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:51:58Z","timestamp":1761155518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358772-gemcitabine-induced-thrombotic-microangiopathy-in-a-patient-with-metastatic-pancreatic-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.95175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}